Eli Lilly, 2 articles today on Seeking Alpha, who
Post# of 148179
The data refers to trials for only mild or moderate covid infections. Confused.
Article says deaths reduced by 70% but this is not explained? Vs placebo?
Article says they applied for EUA from the FDA in November, but wait, before results and before Top Line Report?
How can they report 70% reduction in deaths on a drug that is only given to mild and moderate infected patients?
Such apparent good results and the share price is down half a percent?
Article now they are going into a Phase IV Clinical Trial....